Nathan B. Fountain

13.2k total citations · 2 hit papers
81 papers, 4.7k citations indexed

About

Nathan B. Fountain is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Nathan B. Fountain has authored 81 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Psychiatry and Mental health, 46 papers in Pediatrics, Perinatology and Child Health and 28 papers in Cellular and Molecular Neuroscience. Recurrent topics in Nathan B. Fountain's work include Epilepsy research and treatment (67 papers), Pharmacological Effects and Toxicity Studies (43 papers) and Neuroscience and Neuropharmacology Research (24 papers). Nathan B. Fountain is often cited by papers focused on Epilepsy research and treatment (67 papers), Pharmacological Effects and Toxicity Studies (43 papers) and Neuroscience and Neuropharmacology Research (24 papers). Nathan B. Fountain collaborates with scholars based in United States, United Kingdom and Belgium. Nathan B. Fountain's co-authors include Bassel F. Shneker, Mark Quigg, Eric W. Lothman, Susan T. Herman, Paul C. Van Ness, David A. Eberhard, Soo Ik Lee, Edward H. Bertram, Frank W. Drislane and Nicolas Gaspard and has published in prestigious journals such as New England Journal of Medicine, Neurology and Journal of Neurophysiology.

In The Last Decade

Nathan B. Fountain

80 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Clinical Neurophysiology Society’s Standardized Critical Care EEG Terminology

2013 753 citations Susan T. Herman, Nathan B. Fountain et al. Journal of Clinical Neurophysiology profile →
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

2019 305 citations Jaideep Kapur, Jordan Elm et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathan B. Fountain United States	36	3.3k	2.2k	1.4k	1.2k	739	81	4.7k
Martin Holtkamp Germany	34	2.8k 0.8×	1.9k 0.9×	1.6k 1.1×	787 0.7×	833 1.1×	177	4.5k
E. L. So United States	24	3.3k 1.0×	1.9k 0.9×	1.3k 0.9×	1.1k 0.9×	807 1.1×	33	4.4k
James J. Riviello United States	38	4.1k 1.2×	3.5k 1.6×	1.5k 1.0×	1.4k 1.1×	843 1.1×	148	7.0k
Alan R. Towne United States	23	4.0k 1.2×	3.1k 1.4×	1.5k 1.1×	741 0.6×	524 0.7×	38	4.6k
Suzette M. LaRoche United States	26	2.7k 0.8×	1.7k 0.8×	853 0.6×	1.3k 1.1×	791 1.1×	41	4.0k
Michael Privitera United States	48	5.3k 1.6×	3.8k 1.8×	1.5k 1.0×	1.5k 1.3×	556 0.8×	168	7.7k
Hajo M. Hamer Germany	47	4.2k 1.3×	2.8k 1.3×	2.0k 1.4×	1.9k 1.5×	915 1.2×	275	7.4k
Dennis Dlugos United States	46	4.1k 1.2×	3.2k 1.5×	1.3k 0.9×	1.6k 1.3×	575 0.8×	137	6.7k
Daniel H. Lowenstein United States	31	4.8k 1.4×	3.6k 1.6×	2.5k 1.7×	662 0.5×	863 1.2×	56	6.5k
David Gloss United States	32	3.6k 1.1×	1.6k 0.7×	1.4k 1.0×	1.4k 1.1×	1.1k 1.6×	57	6.5k

Countries citing papers authored by Nathan B. Fountain

Since Specialization

Citations

This map shows the geographic impact of Nathan B. Fountain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan B. Fountain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan B. Fountain more than expected).

Fields of papers citing papers by Nathan B. Fountain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan B. Fountain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan B. Fountain. The network helps show where Nathan B. Fountain may publish in the future.

Co-authorship network of co-authors of Nathan B. Fountain

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan B. Fountain. A scholar is included among the top collaborators of Nathan B. Fountain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan B. Fountain. Nathan B. Fountain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berr, Stuart S., et al.. (2024). An end-to-end deep learning pipeline to derive blood input with partial volume corrections for automated parametric brain PET mapping. Biomedical Physics & Engineering Express. 10(5). 55028–55028.

Bagić, Anto, Shasha Bai, Kevin Chapman, et al.. (2023). Associations between testing and treatment pathways in lesional temporal or extratemporal epilepsy: A census survey of NAEC center directors. Epilepsia. 64(4). 821–830. 1 indexed citations

Krishna, Vibhor, Jesse Mindel, Francesco Sammartino, et al.. (2023). A phase 1 open‐label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy. Epilepsia. 64(4). 831–842. 22 indexed citations

Bagić, Anto, Shasha Bai, Kevin Chapman, et al.. (2022). Association Between Characteristics of National Association of Epilepsy Centers and Reported Utilization of Specific Surgical Techniques. Neurology. 100(7). e719–e727. 2 indexed citations

Bagić, Anto, Shasha Bai, Kevin Chapman, et al.. (2022). Epilepsy center characteristics and geographic region influence presurgical testing in the United States. Epilepsia. 64(1). 127–138. 9 indexed citations

Sathe, Abhishek G., Ellen Underwood, Lisa D. Coles, et al.. (2021). Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial. Epilepsia. 62(3). 795–806. 52 indexed citations

Biton, Victor, António Gil‐Nagel, Jouko Isojärvi, et al.. (2015). Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials. Epilepsy & Behavior. 52(Pt A). 119–127. 71 indexed citations

Fountain, Nathan B., Paul C. Van Ness, Amy Bennett, et al.. (2015). Quality improvement in neurology. Neurology. 84(14). 1483–1487. 80 indexed citations

Greyson, Bruce, et al.. (2014). Out-of-body experiences associated with seizures. Frontiers in Human Neuroscience. 8. 65–65. 23 indexed citations

10.

Fountain, Nathan B.. (2013). Obliterating the Seizure Focus in AVMs is Effective: More Clinical Data Confirming Common Sense. Epiliepsy currents. 13(1). 9–10. 5 indexed citations

11.

Fountain, Nathan B., et al.. (2012). Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide‐naive patients with partial‐onset seizures. Epilepsia. 54(1). 58–65. 45 indexed citations

12.

Huff, J. Stephen & Nathan B. Fountain. (2010). Pathophysiology and Definitions of Seizures and Status Epilepticus. Emergency Medicine Clinics of North America. 29(1). 1–13. 26 indexed citations

13.

Chung, Steve, Elinor Ben‐Menachem, Michael R. Sperling, et al.. (2010). Examining the Clinical Utility of Lacosamide. CNS Drugs. 24(12). 1041–1054. 74 indexed citations

14.

Fountain, Nathan B. & Andrew J. Cole. (2010). Pharmacologic Treatment of Epilepsy. CNS Spectrums. 15(S5). 4–6. 2 indexed citations

15.

Fountain, Nathan B. & John M. Freeman. (2006). EEG Is an Essential Clinical Tool: Pro and Con. Epilepsia. 47(s1). 23–25. 36 indexed citations

16.

Fountain, Nathan B., et al.. (2004). Epilepsy in Football Players and Other Land-based Contact or Collision Sport Athletes. Current Sports Medicine Reports. 3(5). 284–288. 14 indexed citations

17.

Fountain, Nathan B., et al.. (2003). Epilepsy and athletics. Clinics in Sports Medicine. 22(3). 605–616. 33 indexed citations

18.

Fountain, Nathan B., et al.. (2003). Clinical Correlation of Occipital Intermittent Rhythmic Delta Activity. Journal of Clinical Neurophysiology. 20(1). 35–41. 26 indexed citations

19.

Glauser, Tracy A., John M. Pellock, E. Martina Bebin, et al.. (2002). Efficacy and Safety of Levetiracetam in Children with Partial Seizures: An Open‐label Trial. Epilepsia. 43(5). 518–524. 122 indexed citations

20.

Bertram, Edward H., et al.. (1998). Functional anatomy of limbic epilepsy: a proposal for central synchronization of a diffusely hyperexcitable network. Epilepsy Research. 32(1-2). 194–205. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact